Department of Laboratory Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
J Clin Lab Anal. 2019 Nov;33(9):e22989. doi: 10.1002/jcla.22989. Epub 2019 Aug 6.
Two methods were compared for evaluating the sigma metrics of clinical biochemistry tests using two different allowable total error (TEa) specifications.
The imprecision (CV%) and bias (bias%) of 19 clinical biochemistry analytes were calculated using a trueness verification proficiency testing (TPT)-based approach and an internal quality control data inter-laboratory comparison (IQC)-based approach, respectively. Two sources of total allowable error (TEa), the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) and the People's Republic of China Health Industry Standard (WS/T 403-2012), were used to calculate the sigma metrics (σ σ ). Sigma metrics were calculated to provide a single value for assessing the quality of each test based on a single concentration level.
For both approaches, σ > σ in 18 out of 19 assays. For the TPT-based approach, 16 assays showed σ > 3, and 12 assays showed σ > 3. For the IQC-based approach, 19 and 16 assays showed σ > 3 and σ > 3, respectively.
Both methods can be used as references for calculating sigma metrics and designing QC schedules in clinical laboratories. Sigma metrics should be evaluated comprehensively by different approaches.
本研究比较了两种方法,以评估两种不同允许总误差(TEa)规格下临床生化检验的西格玛指标。
分别采用基于真实度验证能力验证(TPT)和基于实验室间室内质量控制数据比较(IQC)的方法,计算了 19 项临床生化分析物的不精密度(CV%)和偏倚(bias%)。使用两个总允许误差(TEa)来源,即 1988 年临床实验室改进修正案(CLIA '88)和中华人民共和国卫生行业标准(WS/T 403-2012),计算了西格玛指标(σ σ )。西格玛指标用于基于单个浓度水平评估每个测试的质量,提供了一个单一的值。
对于两种方法,在 19 项检测中,有 18 项检测的 σ >σ。对于基于 TPT 的方法,16 项检测的 σ >3,12 项检测的 σ >3。对于基于 IQC 的方法,19 项和 16 项检测的 σ >3 和 σ >3。
两种方法均可作为临床实验室计算西格玛指标和设计质控方案的参考。应通过不同方法综合评估西格玛指标。